NXTM Share Price

Open 26.19 Change Price %
High 26.36 1 Day -0.28 -1.06
Low 25.66 1 Week -2.09 -7.44
Close 26.02 1 Month 1.35 5.47
Volume 723258 1 Year 6.56 33.71
52 Week High 28.36
52 Week Low 13.49
NXTM Important Levels
Resistance 2 26.67
Resistance 1 26.40
Pivot 26.01
Support 1 25.64
Support 2 25.37
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
DRYS 1.01 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
CPSL 0.10 66.67%
LOCM 0.09 50.00%
GLBS 9.70 31.79%
LTRE 2.85 29.55%
ETRM 7.96 29.22%
INFI 2.00 29.03%
QKLS 0.14 27.27%
PRKR 2.57 26.60%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
HEAT 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

NxStage Medical, Inc. (NASDAQ: NXTM)

NXTM Technical Analysis 4
As on 20th Jan 2017 NXTM Share Price closed @ 26.02 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 21.33 & Buy for SHORT-TERM with Stoploss of 25.64 we also expect STOCK to react on Following IMPORTANT LEVELS.
NXTM Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
NXTM Other Details
Segment EQ
Market Capital 626582144.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.nxstage.com
NXTM Address
NXTM
350 Merrimack Street
Lawrence, MA 01843
United States
Phone: 978-687-4700
Interactive Technical Analysis Chart NxStage Medical, Inc. ( NXTM NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on NxStage Medical, Inc.
NXTM Business Profile
NxStage Medical, Inc. (NxStage) is a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. The Company�s primary product is the NxStage System One (System One). It also sells needles and blood tubing sets primarily to dialysis clinics for the treatment of end-stage renal disease (ESRD). It operates in two segments: System One and In-Center. It distributes its products in three markets: home, critical care and in-center. In the System One segment it derives its revenues from the sale and rental of the System One and PureFlow SL equipment, and the sale of disposable products in the home and critical care markets. In the In-Center segment, it derives its revenues from the sale of blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers and needles for apheresis, which is referred to as the in-center market.